Literature DB >> 19082787

Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.

A Stecco1, G Romano, M Negru, D Volpe, A Saponaro, S Costantino, G Sacchetti, E Inglese, O Alabiso, A Carriero.   

Abstract

PURPOSE: The aim of this pilot study was to compare positron emission tomography computed tomography (PET-CT) and whole-body DWIBS in staging oncological patients to determine the staging accuracy of whole-body DWIBS.
MATERIALS AND METHODS: We initiated a prospective, blinded investigation on 29 patients affected by oncological diseases (n=14) or lymphoma (n=15), who underwent fluorodeoxyglucose (FDG)-based PET-CT and whole-body DWIBS for restaging purposes. Magnetic resonance (MR) imaging was conducted with a multistack (n=4) DWIBS pulse sequence. Images were read independently by two experienced radiologists and one nuclear physician. Statistical analysis assessed interobserver agreement and diagnostic accuracy.
RESULTS: Whole-body DWIBS had a room occupation time of 20 min. Mean postprocessing time was 15 min (range 10-17 min). Mean reading time was 20 min for reader 1 (range 15-25 min) and 18 min for reader 2 (range 13-22 min). Interobserver agreement was almost perfect (=0.93). Reader 1 had a sensitivity of 89.07%, a specificity of 98.5%, and an accuracy of 97.65%, with a positive predictive value (PPV) of 85.48% and a negative predictive value (NPV) of 98.91%. Reader 2 had a sensitivity of 87.39%, a specificity of 98.39% and a diagnostic accuracy of 97.8%, with a PPV of 88.13% and a NPV of 98.75%.
CONCLUSIONS: The whole-body DWIBS protocol provided a fast whole-body examination with high specificity and NPV. One major bias of the study was the inclusion of patients with diffuse disease and advanced disease stage and the heterogeneity of the neoplastic diseases included.

Entities:  

Mesh:

Year:  2008        PMID: 19082787     DOI: 10.1007/s11547-008-0348-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  17 in total

1.  A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.

Authors:  S Eustace; R Tello; V DeCarvalho; J Carey; J T Wroblicka; E R Melhem; E K Yucel
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

Review 2.  Magnetic resonance diffusion-weighted imaging: extraneurological applications.

Authors:  S Colagrande; S F Carbone; L M Carusi; M Cova; N Villari
Journal:  Radiol Med       Date:  2006-04-11       Impact factor: 3.469

3.  Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Authors:  H E Daldrup-Link; C Franzius; T M Link; D Laukamp; J Sciuk; H Jürgens; O Schober; E J Rummeny
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

4.  Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques.

Authors:  R C Semelka; S Worawattanakul; N L Kelekis; G John; J T Woosley; M Graham; W G Cance
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

5.  Detection of malignant bone tumors: MR imaging vs scintigraphy.

Authors:  J A Frank; A Ling; N J Patronas; J A Carrasquillo; K Horvath; A M Hickey; A J Dwyer
Journal:  AJR Am J Roentgenol       Date:  1990-11       Impact factor: 3.959

6.  Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases.

Authors:  F W Flickinger; S M Sanal
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

7.  Whole-body MRI using a rolling table platform for the detection of bone metastases.

Authors:  Thomas C Lauenstein; Lutz S Freudenberg; Susanne C Goehde; Stefan G Ruehm; Mathias Goyen; Silke Bosk; Jörg F Debatin; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2002-03-08       Impact factor: 5.315

8.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug

9.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

Review 10.  Clinical applications of PET in oncology.

Authors:  Eric M Rohren; Timothy G Turkington; R Edward Coleman
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

View more
  17 in total

1.  Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.

Authors:  A Orlacchio; O Schillaci; E Gaspari; F Della Gatta; R Danieli; F Bolacchi; C Ragano Caracciolo; A Mancini; G Simonetti
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

2.  Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Taoufik El-Gnaoui; Alexandre Vignaud; Pauline Beaussart; Shih-jui Lin; Karim Belhadj; Pierre Brugières; Eva Evangelista; Corinne Haioun; Michel Meignan; Alain Rahmouni
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

3.  Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.

Authors:  Michael A Jacobs; Katarzyna J Macura; Atif Zaheer; Emmanuel S Antonarakis; Vered Stearns; Antonio C Wolff; Thorsten Feiweier; Ihab R Kamel; Richard L Wahl; Li Pan
Journal:  Acad Radiol       Date:  2018-04-04       Impact factor: 3.173

4.  Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum.

Authors:  F Tondo; A Saponaro; A Stecco; M Lombardi; C Casadio; A Carriero
Journal:  Radiol Med       Date:  2011-02-01       Impact factor: 3.469

5.  Improved short tau inversion recovery (iSTIR) for increased tumor conspicuity in the abdomen.

Authors:  Ananth J Madhuranthakam; Karen S Lee; Aya Yassin; Jean H Brittain; Ivan Pedrosa; Neil M Rofsky; David C Alsop
Journal:  MAGMA       Date:  2013-09-20       Impact factor: 2.310

6.  Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.

Authors:  D Cafagna; G Rubini; F Iuele; N Maggialetti; A Notaristefano; D Pinto; A Niccoli-Asabella; G Palmiotti; M Lasciarrea; A Maggialetti
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

7.  Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.

Authors:  A Stecco; M Lombardi; L Leva; M Brambilla; E Negru; S Delli Passeri; A Carriero
Journal:  Radiol Med       Date:  2012-08-08       Impact factor: 3.469

8.  Diagnostic accuracy of diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion for the detection of abdominal solid cancer.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Kazunori Fugo; Satomi Tanaka; Takafumi Sunaoshi; Daisuke Kano; Eriko Sugiyama; Misaki Shite; Ryouta Haga; Yoshiya Fukamizu; Toshiyuki Fujita; Satoshi Kagayama; Rumiko Hasegawa; Akira Togawa; Yoshinori Shirai; Noboru Ichiki; Yuji Oshima; Naoto Koike; Yasuko Toshimitsu; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

Review 9.  Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer.

Authors:  Michael A Jacobs; Li Pan; Katarzyna J Macura
Journal:  Semin Roentgenol       Date:  2009-04       Impact factor: 0.800

10.  Detecting peritoneal dissemination of ovarian cancer in mice by DWIBS.

Authors:  Hye Jeong Lee; Jeffrey J Luci; Mohammed N Tantawy; Haakil Lee; Ki Taek Nam; Todd E Peterson; Ronald R Price
Journal:  Magn Reson Imaging       Date:  2012-08-24       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.